163 related articles for article (PubMed ID: 33525583)
1. Toxicity Reduction after Craniospinal Irradiation via Helical Tomotherapy in Patients with Medulloblastoma: A Unicentric Retrospective Analysis.
Öztunali A; Elsayad K; Scobioala S; Channaoui M; Haverkamp U; Grauer O; Sträter R; Brentrup A; Stummer W; Kerl K; Eich HT
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33525583
[No Abstract] [Full Text] [Related]
2. Outcome and toxicity using helical tomotherapy for craniospinal irradiation in pediatric medulloblastoma.
Lopez Guerra JL; Marrone I; Jaen J; Bruna M; Sole C; Sanchez-Reyes A; Rivin E; Ortiz MJ; Calvo F; Matute R
Clin Transl Oncol; 2014 Jan; 16(1):96-101. PubMed ID: 23632814
[TBL] [Abstract][Full Text] [Related]
3. Craniospinal irradiation using helical tomotherapy: evaluation of acute toxicity and dose distribution.
Sugie C; Shibamoto Y; Ayakawa S; Mimura M; Komai K; Ishii M; Miyamoto A; Oda K
Technol Cancer Res Treat; 2011 Apr; 10(2):187-95. PubMed ID: 21381797
[TBL] [Abstract][Full Text] [Related]
4. Craniospinal irradiation using helical tomotherapy for central nervous system tumors.
Schiopu SR; Habl G; Häfner M; Katayama S; Herfarth K; Debus J; Sterzing F
J Radiat Res; 2017 Mar; 58(2):238-246. PubMed ID: 28096196
[TBL] [Abstract][Full Text] [Related]
5. Helical tomotherapy craniospinal irradiation in primary brain tumours: Toxicities and outcomes in a peadiatric and adult population.
Savagner J; Ducassou A; Cabarrou B; Hangard G; Gambart M; Bertozzi AI; Baudou E; Boetto S; Larrieu D; Laprie A
Clin Transl Radiat Oncol; 2024 May; 46():100777. PubMed ID: 38628594
[TBL] [Abstract][Full Text] [Related]
6. A Comparative Planning Analysis and Integral Dose of Volumetric Modulated Arc Therapy, Helical Tomotherapy, and Three-dimensional Conformal Craniospinal Irradiation for Pediatric Medulloblastoma.
Patel S; Drodge S; Jacques A; Warkentin H; Powell K; Chafe S
J Med Imaging Radiat Sci; 2015 Jun; 46(2):134-140. PubMed ID: 31052086
[TBL] [Abstract][Full Text] [Related]
7. Feasibility and efficacy of helical intensity-modulated radiotherapy for stage III non-small cell lung cancer in comparison with conventionally fractionated 3D-CRT.
He J; Huang Y; Chen Y; Shi S; Ye L; Hu Y; Zhang J; Zeng Z
J Thorac Dis; 2016 May; 8(5):862-71. PubMed ID: 27162660
[TBL] [Abstract][Full Text] [Related]
8. Helical tomotherapy in the treatment of pediatric malignancies: a preliminary report of feasibility and acute toxicity.
Mesbah L; Matute R; Usychkin S; Marrone I; Puebla F; Mínguez C; García R; García G; Beltrán C; Marsiglia H
Radiat Oncol; 2011 Aug; 6():102. PubMed ID: 21871078
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary toxicity of craniospinal irradiation using helical tomotherapy.
Lee J; Kim E; Kim N; Suh CO; Chung Y; Yoon HI
Sci Rep; 2022 Feb; 12(1):3221. PubMed ID: 35217707
[TBL] [Abstract][Full Text] [Related]
10. Late toxicity following craniospinal radiation for early-stage medulloblastoma.
Christopherson KM; Rotondo RL; Bradley JA; Pincus DW; Wynn TT; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
Acta Oncol; 2014 Apr; 53(4):471-80. PubMed ID: 24564687
[TBL] [Abstract][Full Text] [Related]
11. Clinical analysis of intracranial germinoma's craniospinal irradiation using helical tomotherapy.
Qu B; Du L; Huang Y; Yu W; Cai B; Xu S; Ma L
Chin J Cancer Res; 2014 Jun; 26(3):247-54. PubMed ID: 25035651
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of intensive chemotherapy followed by reduced-dose and reduced-field irradiation for intracranial germ cell tumor.
Takada A; Ii N; Hirayama M; Toyoda H; Matsubara T; Toyomasu Y; Kawamura T; Daimon T; Sakuma H; Nomoto Y
J Neurosurg Pediatr; 2018 Nov; 23(3):317-324. PubMed ID: 30497152
[TBL] [Abstract][Full Text] [Related]
13. Hypofractionated Helical Tomotherapy for Older Aged Patients With Prostate Cancer: Preliminary Results of a Phase I-II Trial.
Liu HX; Du L; Yu W; Cai BN; Xu SP; Xie CB; Ma L
Technol Cancer Res Treat; 2016 Aug; 15(4):546-54. PubMed ID: 26152749
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of salvage re-irradiation in recurrent medulloblastoma correlate with age at initial diagnosis, primary risk-stratification, and molecular subgrouping.
Gupta T; Maitre M; Sastri GJ; Krishnatry R; Shirsat N; Epari S; Sahay A; Chinnaswamy G; Patil V; Shetty P; Moiyadi A
J Neurooncol; 2019 Sep; 144(2):283-291. PubMed ID: 31236820
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy after reduced craniospinal irradiation dose in children with average-risk medulloblastoma: a 5-year follow-up study.
Wahba HA; Abu-Hegazy M; Wasel Y; Ismail EI; Zidan AS
J BUON; 2013; 18(2):425-9. PubMed ID: 23818356
[TBL] [Abstract][Full Text] [Related]
16. Preliminary observations on biochemical relapse-free survival rates after short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy/fraction) for localized prostate cancer.
Kupelian PA; Reddy CA; Carlson TP; Altsman KA; Willoughby TR
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):904-12. PubMed ID: 12095556
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy and overall survival in adult medulloblastoma.
Kann BH; Lester-Coll NH; Park HS; Yeboa DN; Kelly JR; Baehring JM; Becker KP; Yu JB; Bindra RS; Roberts KB
Neuro Oncol; 2017 Feb; 19(2):259-269. PubMed ID: 27540083
[TBL] [Abstract][Full Text] [Related]
18. Disease control and ototoxicity using intensity-modulated radiation therapy tumor-bed boost for medulloblastoma.
Polkinghorn WR; Dunkel IJ; Souweidane MM; Khakoo Y; Lyden DC; Gilheeney SW; Becher OJ; Budnick AS; Wolden SL
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e15-20. PubMed ID: 21481547
[TBL] [Abstract][Full Text] [Related]
19. Outcome and prognostic factors following palliative craniospinal irradiation for leptomeningeal carcinomatosis.
El Shafie RA; Böhm K; Weber D; Lang K; Schlaich F; Adeberg S; Paul A; Haefner MF; Katayama S; Sterzing F; Hörner-Rieber J; Löw S; Herfarth K; Debus J; Rieken S; Bernhardt D
Cancer Manag Res; 2019; 11():789-801. PubMed ID: 30697071
[TBL] [Abstract][Full Text] [Related]
20. Pediatric craniospinal irradiation with conventional technique or helical tomotherapy: impact of age and body volume on integral dose.
Barra S; Gusinu M; Timon G; Giannelli F; Vidano G; Garrè ML; Corvò R
Tumori; 2016 Aug; 102(4):387-92. PubMed ID: 27056336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
